Polaris Market Research today announced findings from its latest report, projecting the U.S. CRISPR & Cas genes market to grow from USD 1.54 billion in 2024 to USD 8.29 billion by 2034, at a CAGR of 18.4% between 2025 and 2034. The 129-page report profiles leading companies across product, service, application, and end-use segments shaping the country's gene-editing landscape. CRISPR-Cas...